4.7 Review

Scientific barriers to developing vaccines against avian influenza viruses

Journal

NATURE REVIEWS IMMUNOLOGY
Volume 7, Issue 4, Pages 267-278

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nri2054

Keywords

-

Categories

Funding

  1. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000933, Z01AI000997, ZIAAI000997, Z01AI000933] Funding Source: NIH RePORTER
  2. Intramural NIH HHS Funding Source: Medline

Ask authors/readers for more resources

The increasing number of reports of direct transmission of avian influenza viruses to humans underscores the need for control strategies to prevent an influenza pandemic. Vaccination is the key strategy to prevent severe illness and death from pandemic influenza. Despite long-term experience with vaccines against human influenza viruses, researchers face several additional challenges in developing human vaccines against avian influenza viruses. In this Review, we discuss the features of avian influenza viruses, the gaps in our understanding of infections caused by these viruses in humans and of the immune response to them that distinguishes them from human influenza viruses, and the current status of vaccine development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available